A second flow diverter stent is now commercially available in the U.S. for treating wide-neck intracranial aneurysms. One of its earliest adopters compares and contrasts the two available devices and outlines their place in therapy.
This 19-year-old’s case was marked by significant proximal large vessel tortuosity and extensive prior aortic instrumentation, demanding alternate vascular access with a hybrid approach.
A Cleveland Clinic neurosurgeon argues that states should follow their model for Level 1 trauma centers in making policy for emergency medical transport of stroke patients.
Another large retrospective analysis raises questions around the ARUBA trial’s findings on surgery vs. watch-and-wait for unruptured brain arteriovenous malformations.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
This case study makes clear the value of quantitative vessel imaging to quickly visualize subtle flow abnormalities during aneurysm surgery.